Your session is about to expire
← Back to Search
Electroacupuncture for Neuropathic Pain
Study Summary
This trial will test whether electroacupuncture can help relieve chemotherapy-induced peripheral neuropathy pain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2007 Phase 2 trial • 57 Patients • NCT00071110Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I agree not to start any new pain medications for the first 12 weeks of the study.My pain or neuropathy medication has been the same for the last three months.I am 18 or older and speak English well.I have moderate to severe nerve pain from chemotherapy, scoring 4 or more on a pain scale.I have been diagnosed with CIPN due to symptoms like pain, numbness, or tingling in a pattern that fits like gloves or socks.I experience mild or greater pain.I am willing to follow all study procedures and accept any of the acupuncture treatments.I have no signs of cancer based on recent exams and my health history.I agree not to start any new pain medications for the first 12 weeks of the study.I experience mild or greater pain.I finished chemotherapy that can affect nerves 3 months ago.I have used acupuncture for symptom management in the last year.My pain or neuropathy medication has been the same for the last three months.I have moderate to severe nerve pain from chemotherapy, scoring 4 or more on a pain scale.I am willing to follow all study procedures and accept any of the acupuncture treatments.I have no signs of cancer based on recent exams and my health history.I have moderate to severe nerve pain from chemotherapy, scoring 4 or more on a pain scale.
- Group 1: Sham Acupuncture Arm
- Group 2: Electroacupuncture Arm
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are actively enrolled in this clinical trial at present?
"Yes, active recruitment is underway for this clinical trial according to the information available on clinicaltrials.gov. The listing for this study was first posted on 5/21/2021 and most recently edited on 4/13/2022. This research project needs to enroll 250 patients at 5 different locations."
Are patients currently being registered for this clinical trial?
"Yes, this study is still open and recruiting patients. The listing on clinicaltrials.gov notes that the first posting was on May 21st, 2021 and the most recent edit was done on April 13th, 2022."
How many staff members are managing this research at different sites?
"According to the information available, there are five sites participating in this clinical trial. They are Memorial Sloan Kettering Nassau (Limited protocol activities) in Rockville Centre, Memorial Sloan - Kettering Cancer Center in New york, and Memorial Sloan Kettering Bergen (Limited Protocol Activities) in Montvale. There are also two other locations not mentioned."
Are there any legal barriers to using electroacupuncture?
"Given that this is a Phase 3 trial with evidence of efficacy as well as multiple rounds of data affirming safety, our team has rated the safety of electroacupuncture at a 3."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger